BlackRock’s Inhibikase Therapeutics IKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.32M | Buy |
2,728,168
+2,304,189
| +543% | +$4.49M | ﹤0.01% | 3680 |
|
|
2025
Q1 | $929K | Buy |
423,979
+88,519
| +26% | +$194K | ﹤0.01% | 4168 |
|
|
2024
Q4 | $1.09M | Buy |
+335,460
| New | +$1.09M | ﹤0.01% | 4150 |
|
|
2022
Q2 | – | Sell |
-8,583
| Closed | -$76K | – | 5801 |
|
|
2022
Q1 | $76K | Sell |
8,583
-424
| -5% | -$3.75K | ﹤0.01% | 5254 |
|
|
2021
Q4 | $79K | Buy |
9,007
+550
| +7% | +$4.82K | ﹤0.01% | 5254 |
|
|
2021
Q3 | $96K | Buy |
8,457
+6,195
| +274% | +$70.3K | ﹤0.01% | 5081 |
|
|
2021
Q2 | $38K | Buy |
2,262
+2,167
| +2,281% | +$36.4K | ﹤0.01% | 5152 |
|
|
2021
Q1 | $3K | Buy |
+95
| New | +$3K | ﹤0.01% | 5114 |
|